KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Total Current Liabilities (2016 - 2026)

West Pharmaceutical Services has reported Total Current Liabilities over the past 18 years, most recently at $674.0 million for Q1 2026.

  • Quarterly Total Current Liabilities rose 27.97% to $674.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $674.0 million through Mar 2026, up 27.97% year-over-year, with the annual reading at $654.9 million for FY2025, 18.99% up from the prior year.
  • Total Current Liabilities was $674.0 million for Q1 2026 at West Pharmaceutical Services, up from $654.9 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $674.0 million in Q1 2026 and troughed at $456.7 million in Q3 2022.
  • The 5-year median for Total Current Liabilities is $565.1 million (2022), against an average of $577.8 million.
  • Biggest five-year swings in Total Current Liabilities: grew 29.44% in 2023 and later decreased 18.77% in 2025.
  • Tracing WST's Total Current Liabilities over 5 years: stood at $519.0 million in 2022, then rose by 29.44% to $671.8 million in 2023, then fell by 18.07% to $550.4 million in 2024, then rose by 18.99% to $654.9 million in 2025, then grew by 2.92% to $674.0 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $674.0 million, $654.9 million, and $635.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.